Richard S Finn

Title: Richard S Finn: Innovator in Cancer Research

Introduction

Richard S Finn is a prominent inventor based in Encino, CA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of breast cancers. His innovative work has led to the development of methods and compositions that are crucial for managing cancers that express specific genes.

Latest Patents

Richard S Finn holds a patent titled "Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers." This invention relates to methods and compositions useful in diagnosing, treating, and managing cancers that express particular genes, including moesin, caveolin 1, and yes-associated protein 1. His work in this area has the potential to improve patient outcomes significantly.

Career Highlights

Throughout his career, Richard has worked with notable organizations, including Bristol-Myers Squibb Company and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Richard has collaborated with esteemed colleagues such as Judy Dering and Dennis J Slamon. These partnerships have further enhanced his research and innovation in cancer treatment.

Conclusion

Richard S Finn's contributions to cancer research through his patent and collaborations highlight his dedication to improving cancer diagnosis and treatment. His work continues to pave the way for advancements in the medical field.